CA
NZ
UK
AU
IND
US
Shares of Cardinal Health, Inc. (NYSE: CAH) have received a consensus recommendation of “Moderate Buy” from fourteen research firms currently tracking the stock. Out of these, three analysts rate the stock as “Hold,” while eleven have issued “Buy” ratings.
RadNet, Inc. (NASDAQ: RDNT) reported its second-quarter 2025 financial results, posting record revenue and adjusted earnings. Total revenue for the quarter reached USD 498.2 million, an 8.4% increase from USD 459.8 million in Q2 2024. Adjusted EBITDA rose 12.3% to USD 81.2 million, with …
JPMorgan Chase & Co. has increased its price target for Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) from USD348.00 to USD475.00, according to a report released Wednesday. The firm maintained an “overweight” rating, indicating expectations for further gains from the company’s latest closing price of USD428.14.
Total revenue for the quarter was USD 85.7 million, compared to USD 85.6 million in the second quarter of 2024. Recurring revenue accounted for 95% of total revenue. Financial Health segment revenue, previously referred to as Revenue Cycle Management, was USD 54.3 million, slightly …
Baxter International Inc. (NYSE: BAX) has seen a wave of analyst activity following a series of price target revisions. Barclays recently cut its price target for the medical instruments supplier from USD 41.00 to USD 36.00, while maintaining an “overweight” rating on the stock. …
Mdxhealth (NASDAQ: MDXH) has reported its preliminary financial results for the second quarter and first half of fiscal year 2025, along with a strategic acquisition intended to accelerate its growth trajectory. For the quarter ended June 30, 2025, the company posted a 20% year-over-year …
Alcon (SIX/NYSE: ALC) and STAAR Surgical Company (NASDAQ: STAA) announced a definitive merger agreement under which Alcon will acquire STAAR in a transaction valued at approximately $1.5 billion. The deal, which includes the EVO Implantable Collamer® Lens (EVO ICL™) family, aims to expand Alcon’s …
Zepp Health Corporation (NYSE: ZEPP) announced unaudited financial results for the second quarter of 2025, marking its first year-over-year revenue growth since 2021. Total revenue came in at USD 59.4 million, representing a 46.2% increase over the same period in 2024 and a 54.2% …
Indivior (NASDAQ:INDV) has earned a consensus rating of "Buy" from the five brokerages that are presently covering the stock, according to Reuters. Four research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. …
ImageneBio, Inc. (Nasdaq: IMA) will commence trading on the Nasdaq Capital Market at market open on July 28, 2025, following the completed merger between Inmagene Biopharmaceuticals and Ikena Oncology, Inc. The combined clinical-stage biotechnology company will continue its focus on immunological and inflammatory diseases, …
Please wait processing your request...